We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MORN:NASDAQMorningstar, Inc. analysis

Data as of Oct 15, 2026 - not real-time

Latest price
$203.96
Risk: medium
5/10Medium risk

Summary

The moving-average structure behind Morningstar, Inc. is neutral at $203.96, with no clear ordering between short and long averages. Over a rolling month the price has lost 2.8%. Relative strength is 56.0 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $182.39 and resistance around $208.02.
On valuation the read is overvalued — earnings multiple of 19.4 versus a 15.5 sector average, above the peer group. The average analyst target implies 17.2% above today's level. Revenue is growing at 9.6% on a 16.4% profit margin. The 0.98% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 37.1%, a beta of 0.10 and a maximum drawdown of 36.0%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top market events

  • What Happened? Shares of investment research firm Morningstar NASDAQ:MORN jumped 4.4% in the afternoon session after...
  • Shares of investment research firm Morningstar NASDAQ:MORN jumped 4.
  • CHICAGO, October 05, 2026--Morningstar, Inc.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 185.66
  • MACD momentum is positive
  • Maximum drawdown of 36.0%

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • P/E of 19.4 versus sector average of 15.5
  • Trading above the 200-day average of 185.66
  • Analyst targets imply +17.2% versus the current price

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • P/E of 19.4 versus sector average of 15.5
  • Analyst targets imply +17.2% versus the current price
  • Profit margin of 16.4% is healthy

Key metrics

Financial health

Revenue Growth9.60%
Profit Margin16.43%
P/E Ratio19.4
ROE31.96%
ROA9.63%
Debt/Equity186.05
P/B Ratio7.5
Op. Cash Flow$646.9M
Free Cash Flow$497.8M
Industry P/E15.5

Technical analysis

TrendNeutral
RSI56.0
Support$182.39
Resistance$208.02
MA 20$197.21
MA 50$202.91
MA 200$185.66
MACDBullish
VolumeDecreasing
Fear & Greed Index91.3

Valuation

Fair Value$200.03
Target Price$239.00
Upside/Downside17.18%
GradeOvervalued
TypeGrowth
Dividend Yield0.98%

Risk assessment

Beta0.10
Volatility37.09%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.